Florida Center for Gastroenterology

Largo, Florida 33777

0 studies enrolling now · 20 studies all time

What they study most

Chronic Hepatitis C, Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Genotype 1, H. Pylori Infection, Hepatitis C, Chronic, Irritable Bowel Syndrome, Ulcerative Colitis

Studies at this site

• An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease — Completed
• Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
• Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis — Completed
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome — Completed
• A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
• Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
• Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease — Completed
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed
• ARJ C13 Urea Breath Test System — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling
• An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1 — Completed
• Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy — Completed
• Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C — Completed
• Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients — Completed